TWC
UBX

TD Waterhouse Canada’s Unity Biotechnology UBX Stock Holding History

TD Waterhouse Canada’s Portfolio UBX Stock Details UBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-76
Closed -$539 – 1785
2022
Q2 		$539 Hold
76
– – ﹤0.01% 1665
2022
Q1 		$1.04K Hold
76
– – ﹤0.01% 1669
2021
Q4 		$1.62K Buy
+76
New +$1.66K ﹤0.01% 1611

Other funds holding UBX

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
ACM
Altium Capital Management New York $42M AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

TD Waterhouse Canada's UBX Position: Q3 2022 in Review

TD Waterhouse Canada sold out of Unity Biotechnology (UBX) in Q3 2022, closing a stake of 76 shares — an estimated $539 sold.

TD Waterhouse Canada first reported a position in UBX in Q4 2021 and held it in 3 quarters. The position peaked at $1.62K in Q4 2021. 72 funds tracked by Wall St. Rank hold UBX as of Q3 2022.

  • TD Waterhouse Canada reported no remaining Unity Biotechnology position as of Q3 2022 after selling out during the quarter.
  • TD Waterhouse Canada sold 76 Unity Biotechnology shares in Q3 2022, an estimated $539.
  • TD Waterhouse Canada first reported a position in Unity Biotechnology in Q4 2021 and held it in 3 quarters.
  • TD Waterhouse Canada's Unity Biotechnology position peaked at $1.62K in Q4 2021.
  • 72 funds tracked by Wall St. Rank held Unity Biotechnology as of Q3 2022.

Based on TD Waterhouse Canada's 13F filing for Q3 2022, filed 13 Nov 2023.